Home›Stock Screener›Influx Healthtech

Influx Healthtech Share Price Today | Stock Price & Influx Healthtech Share Screener

INFLUX Pharmaceuticals & Biotechnology

Track the current Influx Healthtech share price and stock price live with TickJournal's free stock screener. Track Influx Healthtech marketcap in USD to gauge the company's total market size. Use the Influx Healthtech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Influx Healthtech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Influx Healthtech Market Cap ₹643.58 Cr.
INFLUX P/E Ratio (TTM) -
Influx Healthtech P/B Ratio 6.39
EPS (TTM) ₹9.35
Dividend Yield -
Debt to Equity -
INFLUX 52 Week High -
Influx Healthtech 52 Week Low -
Operating Margin -
Profit Margin -
INFLUX Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹124.00
Total Equity ₹101.00

Influx Healthtech Share Price Chart

Track the current stock price of Influx Healthtech with an interactive chart. Analyse INFLUX share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Influx Healthtech stock quote in one place.

Influx Healthtech Company Profile - Fundamental Screener

Screen Influx Healthtech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INFLUX shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0MYZ01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0MYZ01012

Influx Healthtech Balance Sheet Screener

Screen INFLUX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹124.

Latest statistics put total assets at ₹124 and shareholder funds at ₹101.

Item 2026

Assets

Total Assets 124
Current Assets 0
Fixed Assets 28

Liabilities

Total Liabilities 0
Current Liabilities 0
Non-Current Liabilities 0

Shareholders' Equity

Total Equity 101
Share Capital 23
Reserves & Surplus 78

Influx Healthtech Income Statement Screener - Profit & Revenue Analysis

Screen Influx Healthtech income statement and profit fundamentals. Analyze INFLUX quarterly results. Influx Healthtech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹148 and net profit of ₹21.

Item None-None 2026-March

Revenue and Expenses

Revenue 0 148
Expenses 0 117

Operating Costs and Margins

EBITDA 0 31
Operating Profit % 0.00% 20.00%
Depreciation 0 4
Interest 0 0

Profit and Earnings

Profit Before Tax 0 27
Tax 0 7
Net Profit 0 21
EPS 0.00 9.35

Influx Healthtech Cash Flow Screener - Liquidity Fundamentals

Screen INFLUX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹4, and net cash flow was an inflow of ₹23.

Over the same period, investing activities used ₹25 and financing activities provided ₹45.

Item 2026-March

Cash from Operations and Investing

Operating Activities 4
Investing Activities -25

Financing and Net Cash

Financing Activities 45
Net Cash Flow 23

Influx Healthtech Shareholding Pattern Screener

See Influx Healthtech shareholding pattern with promoter, FII, and DII holdings. Check Influx Healthtech promoter holding and ownership changes for INFLUX on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 73.53%, foreign institutions 0.16%, domestic institutions 5.65% and the public 16.14%, spread across 1,335 shareholders.

The shareholder count was 1,335 in 2026-Mar, compared with 1,296 in 2026-Sept.

Item 2026-Mar 2026-Sept 2025-Feb 2025-Jun 2025-Sept 2024-Sept 2024-Oct

Promoter Holding

Promoter Holding 73.53% 73.53% 99.86% 73.53% 73.53% 99.86% 99.86%

Institutional Investors

FII Holding 0.16% 0.41% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 5.65% 7.33% 0.00% 0.32% 0.07% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 16.14% 14.70% 0.00% 10.89% 13.92% 0.00% 0.00%
Other Holding 4.52% 4.03% 0.14% 15.25% 12.48% 0.14% 0.14%
Shareholder Count 1,335 1,296 9 9 1,022 9 9

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Influx Healthtech. Influx Healthtech dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Influx Healthtech.

Influx Healthtech Stock Index Membership - Nifty & Sensex

See which indices include Influx Healthtech stock. Check INFLUX index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Influx Healthtech is not part of any tracked indices.
Only major market indices are tracked in our system.

Influx Healthtech Market Events Screener - Corporate Actions

Get Influx Healthtech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Influx Healthtech stock events that may affect INFLUX share price, along with derivatives, futures and options activity and sector gainers.

3 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.

It is followed by Quarterly Result Announcement dated May 20, 2026 and Quarterly Result Announcement dated November 12, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-11-04 2026-11-04 Quarterly Result Announcement NA 5.77%
2026-05-20 2026-05-20 Quarterly Result Announcement NA -0.84%
2025-11-12 2025-11-12 Quarterly Result Announcement NA 2.92%

Influx Healthtech Competitors Screener - Peer Stocks Comparison

Screen INFLUX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,036 40.80 61,674 12.69% 11,565 60.77
Divis Laboratories 293,316 87.70 11,067 13.95% 2,568 65.94
Torrent Pharmaceuticals 175,376 84.70 13,886 20.34% 2,138 42.26
Laurus Labs 125,488 94.90 6,868 22.01% 890 55.82
Zydus Life Science 119,900 27.90 27,658 17.64% 5,026 55.22
Dr Reddys Laboratories 116,705 42.00 35,059 3.90% 4,158 73.09
Cipla 114,474 39.20 29,045 2.24% 3,870 62.07
Mankind Pharma 108,424 47.50 14,636 14.85% 1,938 62.66
Aurobindo Pharma 103,355 25.90 34,145 5.56% 3,503 60.69
Lupin 90,173 17.10 29,039 26.75% 5,356 44.73

Influx Healthtech Company Announcements - News & Reports Screener

Screen INFLUX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 6.39. Market capitalisation stands at ₹643.58 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 19, 2026. This page covers 1 balance sheet periods, 2 income statement periods, 1 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.